MACRAMÉ colleagues from EMPA have published a study on Data-Driven Prediction of Nanoparticle Biodistribution from Physicochemical Descriptors.
MACRAMÉ colleagues from EMPA and Epithelix have published a paper entitled ‘Silicon Carbide Nanowires Impair Mucociliary Clearance-Mediated Innate Immunity in Primary Human Bronchial Epithelial Cells’. In this study, the fate of zero-dimensional, one-dimensional, and two-dimensional silicon- and carbon-based nanomaterials was investigated for the first time.
The MACRAMÉ Project team has published an Innovation Report about its Project’s R&I approach. In the paper entitled ‘MACRAMÉ – Advanced characterisation methodologies to assess and predict the health and environmental risks of advanced materials‘, the authors describe the planned information-flow between the different R&I activities conducted in the Project (see
FILK Freiberg Institute gGmbH is an industrial research institution with focus on research and development for small and medium-sized enterprises (SMEs). The history of the institute starts in 1889 with focus on the leather and tanning industry. …
Advanced materials bring new challenges for safety and sustainability assessment. To address these, the EU Horizon Europe projects iCare, MACRAMÉ, and nanoPASS are hosting a Joint Summit to address the needs of industry and regulators in assessing the safety and sustainability of advanced materials. …
The 3rd webinar in the series of MACRAMÉ Webinars on Harmonisation, Standardisation & Validation of Test- and Characterisation Methods focussed on the topic Overcoming issues in regulatory testing of advanced materials. …
Advanced materials bring new challenges for safety and sustainability assessment. To address these, the EU Horizon Europe projects iCare, MACRAMÉ, and nanoPASS are hosting a Joint Summit to address the needs of industry and regulators in assessing the safety and sustainability of advanced materials. …
The webinar will inform you about different standardisation organisations (e.g. ISO, CEN, OECD) and the process towards an accepted standard. This includes the important steps of method validation and regulatory acceptance. An overview of the state-of-the-art of human health and environmental in vitro testing of the advanced materials will be given. …
MEDICA S.p.A. is a prominent firm specializing in electromedical devices and single-use medical products, boasting more than 50 patents and a dedicated emphasis on innovation and research. Utilizing capillary membrane spinning technology for blood and water purification sets this company apart as the sole Italian entity, showcasing its continuous commitment to technological progress. …
The MACRAMÉ Project was invited to give evidence to the 5th Stakeholder Workshop on ‘Safe & Sustainable by Design’, hosted by the European Commission on the 5. and 6. December 2024 in Brussels. Based on the feedback that the MACRAMÉ Project had provided during the second testing period, the Project
Colleagues from the MACRAMÉ Partner University Birmingham contributed to a new review paper. The study conducts an exhaustive analysis of the state-of-the-art developments in the creation and enhancement of MXene-based membranes. Membranes have become a basis in tackling the global challenge of freshwater scarcity, notably in the fields of desalination and water purification.
The European Green Deal sets a roadmap for a sustainable future by 2050, aiming for a toxic-free environment and a circular economy. Key strategies include the Zero Pollution Ambition, the Circular Economy Action Plan, and the Chemicals Strategy for Sustainability. Central to these efforts is the Safe and Sustainable by
Sign up below to receive the MACRAMÉ Newsletter.
Continuing the NanoHarmony NANOMET journey:
Two Days focused on the Standardisation Roadmaps for in vitro Models and Graphene
*** ONLINE ***
22. – 23. November 2023, 10:00 – 15:00 CET
Challenges in addressing Sustainability in the Life Cycle Assessment of Products including Advanced Materials
*** BAuA, Berlin ***
27. – 28. November 2023
The MACRAMÉ to inform and train practitioners of advanced materials’ (AdMas’) safety and sustainability on and in topics pertaining to the harmonisation, standardisation and validation of characterisation- and test-methods of AdMAs.
Please follow this links below to find out more about each one of the webinars offered.
Date & Time: 09. April 2024, 14:00 – 16:00 CEST
Metrology, method validation, standardisation …
These concepts may sound complicated, but they are essential in analytical sciences. They strongly support the development of innovative products such as advanced materials or nanomedicine.
This webinar aims to help increase the impact of the protocols you are developing beyond the academic community and to get you updated on the new standards and reference materials on the horizon. … more …
Date & Time: 11. April 2024, 14:00 – 16:00 CEST
Regulatory safety testing of chemicals and materials is still mainly focused on animal testing. A huge number of New Approach Methodologies (NAMs) to replace or reduce animal testing have been scientifically developed within the last years. Their regulatory use, however, is still limited. A possible way to include NAMs into regulatory testing may be found in Adverse Outcome Pathways (AOPs). We will present what AOPs are, how they can be developed and established at OECD. The AOP for pulmonary fibrosis and the AOP on acute lung toxicity will serve as examples for the development of nanomaterial-relevant AOPs. We will discuss the implementation of AOPs into regulatory testing and hurdles. … more …
Date & Time: 04. March 2025, 14:00 – 16:00 CET
Advanced materials bring new challenges for regulatory risk assessment. The special properties of advanced materials may affect the applicability and predictivity of standard test methods for human health and environmental risk assessment. As a result, test methods may need to be adapted or newly developed.
The webinar will inform you about different standardisation organisations (e.g. ISO, CEN, OECD) and the process towards an accepted standard. This includes the important steps of method validation and regulatory acceptance. An overview of the state-of-the-art of human health and environmental in vitro testing of the advanced materials will be given. Challenges and ways to overcome these will be discussed. Topics include stable dispersions, characterisation of materials in test media, alternative testing approaches and dosimetry.
Join us for an interactive webinar with participants from academia, industry and regulation. … more …
Date & Time: 25. Sept. 2025, 14:00 – 16:00 CEST
Advanced materials go beyond conventional nanomaterials in complexity and functionality, which may bring additional challenges in their risk assessment. The MACRAMÉ Informed Recommendations address critical gaps in the standardisation of testing and risk assessment for advanced materials and highlight the regulatory needs for further developments of test and assessment strategies. The recommendations reflect the scientific and technical knowledge gained during the development of testing methodologies for advanced materials, as well as expert input from regulatory and policy consultations.
Within this interactive webinar we aim to gain your feedback on the recommendations. This will help us refine and further develop the recommendations. Your input will thus support the efforts to align testing strategies with regulatory needs and contribute to more targeted and applicable test method development. . … more …
Continuing the NanoHarmony NANOMET journey:
Two Days focused on the Standardisation Roadmaps for in vitro Models and Graphene
*** ONLINE ***
18th & 19th November 2024
19th & 20th June 2025
OECD Conference Centre, Paris
Continuing the NanoHarmony NANOMET journey:
– Where did our research projects get us, and where do we go from here?
*** ONLINE ***
3rd & 4th November 2025
